• SENSEX 72,822.35
    -427.04 (--0.58%)
  • BANKNIFTY 54,925.70
    -51.20 (--0.09%)
Back

Corporate News

Alivus Life Sciences to review financial results at board meeting October 29, 2026
21-Oct-2026, 05:57

Alivus Life Sciences Limited, formerly Glenmark Life Sciences Limited, will hold a board meeting on Thursday, October 29, 2026, to consider and approve the unaudited financial results for the quarter and half year ended September 30, 2026, and has closed the trading window for its designated persons from October 1, 2026, to October 31, 2026, in accordance with SEBI regulations.